MRKR – Marker Therapeutics Inc
Marker Therapeutics, Inc.MRKR
$1.13Name : Marker Therapeutics, Inc.
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $12,729,150.00
EPSttm : -1.19
Marker Therapeutics, Inc.
$1.13
1.32%$0.015Float Short %
1.6
Margin Of Safety %
Put/Call OI Ratio
EPS Next Q Diff
EPS Last/This Y
-0.1
EPS This/Next Y
-0.38
Price
1.14
Target Price
8.17
Analyst Recom
1
Performance Q
-26.45
Relative Volume
0.23
Beta
1.33
Ticker: MRKR
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-04-14 | MRKR | 1.11 | N/A | N/A | 0 |
| 2025-04-15 | MRKR | 1.167 | N/A | N/A | 0 |
| 2025-04-16 | MRKR | 1.06 | N/A | N/A | 0 |
| 2025-04-17 | MRKR | 1.1655 | N/A | N/A | 0 |
| 2025-04-18 | MRKR | 1.15 | N/A | N/A | 0 |
| 2025-04-21 | MRKR | 1.196 | N/A | N/A | 0 |
| 2025-04-22 | MRKR | 1.2 | N/A | N/A | 0 |
| 2025-04-23 | MRKR | 1.17 | N/A | N/A | 0 |
| 2025-04-24 | MRKR | 1.25 | N/A | N/A | 0 |
| 2025-04-25 | MRKR | 1.25 | N/A | N/A | N/A |
| 2025-04-28 | MRKR | 1.26 | N/A | N/A | N/A |
| 2025-04-29 | MRKR | 1.22 | N/A | N/A | 0 |
| 2025-04-30 | MRKR | 1.19 | N/A | N/A | 0 |
| 2025-05-01 | MRKR | 1.2 | N/A | N/A | 0 |
| 2025-05-02 | MRKR | 1.25 | N/A | N/A | 0 |
| 2025-05-05 | MRKR | 1.23 | N/A | N/A | 0 |
| 2025-05-06 | MRKR | 1.14 | N/A | N/A | 0 |
| 2025-05-07 | MRKR | 1.11 | N/A | N/A | 0 |
| 2025-05-08 | MRKR | 1.28 | N/A | N/A | 0 |
| 2025-05-09 | MRKR | 1.16 | N/A | N/A | 0 |
| 2025-05-12 | MRKR | 1.14 | N/A | N/A | 0 |
| 2025-05-13 | MRKR | 1.12 | N/A | N/A | 0 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-04-14 | MRKR | 1.10 | -18.5 | - | -1.29 |
| 2025-04-15 | MRKR | 1.17 | -18.5 | - | -1.29 |
| 2025-04-16 | MRKR | 1.07 | -18.5 | - | -1.29 |
| 2025-04-17 | MRKR | 1.15 | -18.5 | - | -1.29 |
| 2025-04-18 | MRKR | 1.15 | -18.5 | - | -1.29 |
| 2025-04-21 | MRKR | 1.15 | -18.5 | - | -1.29 |
| 2025-04-22 | MRKR | 1.19 | -18.5 | - | -1.29 |
| 2025-04-23 | MRKR | 1.17 | -18.5 | - | -1.29 |
| 2025-04-24 | MRKR | 1.27 | -18.5 | - | -1.29 |
| 2025-04-25 | MRKR | 1.25 | -18.5 | - | -1.29 |
| 2025-04-28 | MRKR | 1.26 | -18.5 | - | -1.29 |
| 2025-04-29 | MRKR | 1.23 | -18.5 | - | -1.29 |
| 2025-04-30 | MRKR | 1.19 | -18.5 | - | -1.29 |
| 2025-05-01 | MRKR | 1.19 | -18.5 | - | -1.29 |
| 2025-05-02 | MRKR | 1.25 | -18.5 | - | -1.29 |
| 2025-05-05 | MRKR | 1.23 | -18.5 | - | -1.29 |
| 2025-05-06 | MRKR | 1.14 | -18.5 | - | -1.29 |
| 2025-05-07 | MRKR | 1.11 | -18.5 | - | -1.29 |
| 2025-05-08 | MRKR | 1.28 | -18.5 | - | -1.29 |
| 2025-05-09 | MRKR | 1.16 | -18.5 | - | -1.29 |
| 2025-05-12 | MRKR | 1.14 | -18.5 | - | -1.29 |
| 2025-05-13 | MRKR | 1.14 | -18.5 | - | -1.29 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-04-14 | MRKR | 21.17 | 2.45 | 5.36 |
| 2025-04-15 | MRKR | 21.17 | 2.45 | 5.36 |
| 2025-04-16 | MRKR | 21.17 | 2.45 | 5.36 |
| 2025-04-17 | MRKR | 21.17 | 2.45 | 5.36 |
| 2025-04-18 | MRKR | 21.17 | 2.45 | 5.36 |
| 2025-04-21 | MRKR | 21.17 | 2.45 | 5.36 |
| 2025-04-22 | MRKR | 21.17 | 2.45 | 5.36 |
| 2025-04-23 | MRKR | 21.18 | 2.45 | 5.36 |
| 2025-04-24 | MRKR | 21.18 | 2.45 | 5.36 |
| 2025-04-25 | MRKR | 21.17 | 2.45 | 5.36 |
| 2025-04-28 | MRKR | 21.17 | 2.45 | 2.64 |
| 2025-04-29 | MRKR | 21.17 | 2.45 | 2.64 |
| 2025-04-30 | MRKR | 19.81 | 2.45 | 2.64 |
| 2025-05-01 | MRKR | 19.81 | 2.45 | 2.50 |
| 2025-05-02 | MRKR | 19.82 | 2.45 | 2.50 |
| 2025-05-05 | MRKR | 19.83 | 2.45 | 2.50 |
| 2025-05-06 | MRKR | 19.83 | 2.45 | 2.50 |
| 2025-05-07 | MRKR | 19.81 | 2.45 | 2.50 |
| 2025-05-08 | MRKR | 19.81 | 2.45 | 2.50 |
| 2025-05-09 | MRKR | 19.82 | 2.45 | 2.50 |
| 2025-05-12 | MRKR | 19.83 | 2.46 | 1.60 |
| 2025-05-13 | MRKR | 19.83 | 2.46 | 1.60 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
Avg. EPS Est. Current Quarter
-0.28
Avg. EPS Est. Next Quarter
-0.48
Insider Transactions
19.83
Institutional Transactions
2.46
Beta
1.33
Average Sales Estimate Current Quarter
1
Average Sales Estimate Next Quarter
Fair Value
Quality Score
23
Growth Score
25
Sentiment Score
35
Actual DrawDown %
97
Max Drawdown 5-Year %
-98
Target Price
8.17
P/E
Forward P/E
PEG
P/S
1.96
P/B
0.66
P/Free Cash Flow
EPS
-1.2
Average EPS Est. Cur. Y
-1.29
EPS Next Y. (Est.)
-1.67
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-162.82
Relative Volume
0.23
Return on Equity vs Sector %
-81.5
Return on Equity vs Industry %
-64.6
EPS 1 7Days Diff
0.1
EPS 1 30Days Diff
0.9
EBIT Estimation
Marker Therapeutics, Inc.Sector: Healthcare
Industry: Biotechnology
Employees: 5
Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, engages in the development and commercialization of novel T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications. Its multi tumor associated antigen-specific T cell technology is based on the manufacture of non-engineered tumor-specific T cells that recognize multiple tumor-associated antigens. The company also develops MT-401-OTS for the treatment of acute myeloid leukemia AND myelodysplastic syndromes; and MT-601 to treat lymphoma and pancreatic cancer. Marker Therapeutics, Inc. is headquartered in Houston, Texas.
stock quote shares MRKR – Marker Therapeutics Inc Stock Price stock today
news today MRKR – Marker Therapeutics Inc stock forecast ,stock prediction 2023 2024 2025
marketwatch MRKR – Marker Therapeutics Inc yahoo finance google finance
stock history MRKR – Marker Therapeutics Inc invest stock market
stock prices MRKR premarket after hours
ticker MRKR fair value insiders trading